DK1861509T3 - Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller - Google Patents

Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller Download PDF

Info

Publication number
DK1861509T3
DK1861509T3 DK05725638.0T DK05725638T DK1861509T3 DK 1861509 T3 DK1861509 T3 DK 1861509T3 DK 05725638 T DK05725638 T DK 05725638T DK 1861509 T3 DK1861509 T3 DK 1861509T3
Authority
DK
Denmark
Prior art keywords
progression
prevention
procedure
free
breast cancer
Prior art date
Application number
DK05725638.0T
Other languages
English (en)
Inventor
Jeffrey W Allard
Gerald V Doyle
Daniel F Comprehensive Cancer Center Hayes
Michael Craig Miller
Leon W M M Terstappen
Original Assignee
Janssen Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics Llc filed Critical Janssen Diagnostics Llc
Application granted granted Critical
Publication of DK1861509T3 publication Critical patent/DK1861509T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
DK05725638.0T 2005-03-14 2005-03-14 Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller DK1861509T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/008602 WO2006104474A2 (en) 2005-03-14 2005-03-14 A method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells

Publications (1)

Publication Number Publication Date
DK1861509T3 true DK1861509T3 (da) 2015-12-07

Family

ID=37053815

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05725638.0T DK1861509T3 (da) 2005-03-14 2005-03-14 Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller

Country Status (6)

Country Link
EP (1) EP1861509B1 (da)
JP (1) JP2008533487A (da)
CA (1) CA2600225C (da)
DK (1) DK1861509T3 (da)
PL (1) PL1861509T3 (da)
WO (1) WO2006104474A2 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBO20040420A1 (it) 2004-07-07 2004-10-07 Type S R L Macchina per taglio e formatura di piattine metalliche
ITBO20050481A1 (it) 2005-07-19 2007-01-20 Silicon Biosystems S R L Metodo ed apparato per la manipolazione e/o l'individuazione di particelle
US7993821B2 (en) 2005-08-11 2011-08-09 University Of Washington Methods and apparatus for the isolation and enrichment of circulating tumor cells
US8173413B2 (en) 2005-08-11 2012-05-08 University Of Washington Separation and concentration of biological cells and biological particles using a one-dimensional channel
ITBO20050646A1 (it) 2005-10-26 2007-04-27 Silicon Biosystem S R L Metodo ed apparato per la caratterizzazione ed il conteggio di particelle
ITTO20060226A1 (it) 2006-03-27 2007-09-28 Silicon Biosystem S P A Metodo ed apparato per il processamento e o l'analisi e o la selezione di particelle, in particolare particelle biologiche
CN101600966B (zh) 2006-06-02 2014-07-02 辉瑞产品公司 循环肿瘤细胞分析
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US8841135B2 (en) 2007-06-20 2014-09-23 University Of Washington Biochip for high-throughput screening of circulating tumor cells
ITTO20070771A1 (it) 2007-10-29 2009-04-30 Silicon Biosystems Spa Metodo e apparato per la identificazione e manipolazione di particelle
US8071395B2 (en) 2007-12-12 2011-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for magnetic separation of cells
IT1391619B1 (it) * 2008-11-04 2012-01-11 Silicon Biosystems Spa Metodo per l'individuazione, selezione e analisi di cellule tumorali
US10895575B2 (en) 2008-11-04 2021-01-19 Menarini Silicon Biosystems S.P.A. Method for identification, selection and analysis of tumour cells
SG174459A1 (en) 2009-03-17 2011-10-28 Silicon Biosystems Spa Microfluidic device for isolation of cells
JP6017845B2 (ja) * 2011-06-10 2016-11-02 帝人ファーマ株式会社 Ｇｐｉアンカータンパク質欠損細胞の検出方法
ITTO20110990A1 (it) 2011-10-28 2013-04-29 Silicon Biosystems Spa Metodo ed apparato per l'analisi ottica di particelle a basse temperature
ITBO20110766A1 (it) 2011-12-28 2013-06-29 Silicon Biosystems Spa Dispositivi, apparato, kit e metodo per il trattamento di un campione biologico
RU2547561C1 (ru) * 2013-12-18 2015-04-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ульяновский государственный университет" Способ прогнозирования пятилетней выживаемости пациенток с инфильтрирующим раком молочной железы путем определения суммарного балла злокачественности
JP6936984B2 (ja) 2016-01-19 2021-09-22 東ソー株式会社 希少細胞を用いて癌患者の予後を予測する方法
JP2019158777A (ja) * 2018-03-16 2019-09-19 東ソー株式会社 腫瘍マーカーならびに腫瘍細胞を夾雑細胞と区別して回収および検出する方法
CN113284612B (zh) * 2021-05-21 2024-04-16 大连海事大学 一种基于XGBoost算法的生存分析方法
WO2023180465A1 (en) * 2022-03-23 2023-09-28 University Of Twente A magnetic micro-needle to isolate single immunomagnetically labeled cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993388A (en) 1997-07-01 1999-11-30 Kattan; Michael W. Nomograms to aid in the treatment of prostatic cancer
JP2002503814A (ja) * 1998-02-12 2002-02-05 イムニベスト・コーポレイション 循環ガン細胞の迅速かつ効率的な単離のための方法および試薬
WO2000047998A1 (en) 1999-02-10 2000-08-17 Cell Works Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
EP1425383A4 (en) * 2001-08-23 2005-11-09 Immunivest Corp STABILIZATION OF CELLS AND BIOLOGICAL PREPARATIONS FOR ANALYSIS
AU2003242815A1 (en) * 2002-03-13 2003-09-22 Biomerieux Method for the characterisation of circulating tumour cells stemming from solid cancers
CA2516795C (en) * 2003-02-27 2013-01-15 Immunivest Corporation Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients

Also Published As

Publication number Publication date
CA2600225A1 (en) 2006-10-05
WO2006104474A3 (en) 2007-02-22
EP1861509A4 (en) 2010-04-14
CA2600225C (en) 2016-06-28
EP1861509B1 (en) 2015-09-09
EP1861509A2 (en) 2007-12-05
PL1861509T3 (pl) 2016-01-29
WO2006104474A2 (en) 2006-10-05
JP2008533487A (ja) 2008-08-21

Similar Documents

Publication Publication Date Title
DK1861509T3 (da) Fremgangsmåde til forudsigelse af progressionsfri og overordnet overlevelse for hvert opfølgningstidspunkt under behandling af patienter med metastatisk brystkræft under anvendelse af cirkulerende tumorceller
DK1802625T3 (da) Disubstituerede pyrazolobenzodiazepiner der er nyttige som inhibitorer af CDK2 og angiogenese og til behandling af bryst-, tyktarms-, lunge- og prostatacancer
EP1888786A4 (en) USE FREE CIRCULATIVE DNA FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF CANCER
EP1737472A4 (en) EFFECTIVE TREATMENT OF TUMORS AND CANCER USING TRICIRIBIN AND ASSOCIATED COMPOUNDS
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
IL215896A0 (en) Compounds and methods for treatment of cancer
EP1937845A4 (en) MICRO-RNA-BASED METHOD AND COMPOSITIONS FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF BREAST CANCER
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
SI2100618T1 (sl) Antagonisti receptorja za zdravljenje metastaznega kostnega raka
EP1814909A4 (en) USE OF AIMP2DX2 FOR THE DIAGNOSIS AND TREATMENT OF CANCER
DK2173337T3 (da) Phosphaplatiner og deres anvendelse i behandlingen af cancer, der er resistent over for cisplatin og carboplatin
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
IL182813A0 (en) Methods and systems for prognosis and treatment of solid tumors
DK1611890T3 (da) Fremgangsmåde til evaluering og behandling af cancer
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
HK1164767A1 (en) Compounds and methods for the treatment of cancer
DK1694364T3 (da) System til behandling og forebyggelse af brystcancer
CY1117701T1 (el) Δραστηριοτητα του τέμσιρολιμου κατα των ογκων στον καρκινο θηλοειδων νεφρικων κυτταρων
ZA200709542B (en) Combination therapy in the treatment of cancer
AU2003294324A8 (en) Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression
EP1797430A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER
DK1962094T3 (da) Detektionsmiddel og terapeutisk middel til højmalign brystcancer
ZA200706871B (en) Treatment of metastasized tumors
EP1766051A4 (en) METHOD FOR IDENTIFYING BREAST CANCER RISK AND TREATMENTS THEREOF
HK1209754A1 (en) Compounds and methods for the treatment of cancer